Isracann Biosciences Inc. announce that previously shipped genetics have cleared Israeli customs and are being raised as mother stock. The three strains sent were developed as part of United Greeneries' “Grass Roots” genetics program, the goal of which is to produce novel high THC strains with commercially high yields. Currently being sold as premium cannabis flower in Canada, the three strains represent some of the top preforming genetics in United Greeneries' catalogue.

With the support of United Greeneries and Isracann, all three strains have been integrated into the Intelicanna facility and are being prepared as the initial Israeli mother stock.